132 related articles for article (PubMed ID: 2781858)
1. Immunoenhancement with combined rabies and aluminium-adjuvanted tetanus vaccines.
Phanuphak P; Khaoplod P; Sriwanthana B; Phanpanich T; Wongurai S; Roumiantzeff M
Vaccine; 1989 Jun; 7(3):249-52. PubMed ID: 2781858
[TBL] [Abstract][Full Text] [Related]
2. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
[TBL] [Abstract][Full Text] [Related]
3. Combined tetanus-rabies vaccination.
Léry L; Rotivel Y; Trabaud MA; Parvaz P; Mouterde S; Relyveld EH
Dev Biol Stand; 1986; 65():209-20. PubMed ID: 3556772
[TBL] [Abstract][Full Text] [Related]
4. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
5. Performance of aluminium hydroxide gel and oil adjuvant rabies vaccines in bovines.
Reddy GS; Srinivasan VA
Zentralbl Bakteriol; 1997 Nov; 286(4):523-6. PubMed ID: 9440201
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial.
Lang J; Hoa DQ; Gioi NV; Vien NC; Nguyen CV; Rouyrre N; Forrat R
Trans R Soc Trop Med Hyg; 1999; 93(2):208-13. PubMed ID: 10450451
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine.
Phanuphak P; Khawplod P; Sirivichayakul S; Siriprasomsub W; Ubol S; Thaweepathomwat M
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):33-7. PubMed ID: 3620048
[TBL] [Abstract][Full Text] [Related]
8. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.
Li R; Huang L; Li J; Mo Z; He B; Wang Y; Wu X; Minutello M; Guinet-Morlot F; Pichon S
Vaccine; 2013 Dec; 31(50):5940-7. PubMed ID: 24148575
[TBL] [Abstract][Full Text] [Related]
9. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
[TBL] [Abstract][Full Text] [Related]
10. Post exposure rabies prophylaxis with Purified Verocell Rabies Vaccine: a study of immunoresponse in pregnant women and their matched controls.
Sudarshan MK; Madhusudana SN; Mahendra BJ; Ashwathnarayana DH; Jayakumary M; Gangaboriah
Indian J Public Health; 1999; 43(2):76-8. PubMed ID: 11243072
[TBL] [Abstract][Full Text] [Related]
11. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
[TBL] [Abstract][Full Text] [Related]
12. A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
Pichon S; Guinet-Morlot F; Minutello M; Donazzolo Y; Rouzier R; Chassard D; Fitoussi S; Hou V
Vaccine; 2013 Apr; 31(18):2295-301. PubMed ID: 23510665
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2011 Jul; 414(1-2):140-7. PubMed ID: 21605644
[TBL] [Abstract][Full Text] [Related]
14. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.
Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR
Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
[TBL] [Abstract][Full Text] [Related]
17. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
18. Immune response in cattle induced by inactivated rabies vaccine adjuvanted with aluminium hydroxide either alone or in combination with avridine.
Côrtes JA; Rweyemamu MM; Ito FH; Umehara O; Medeiros Neto RR; De Lucca-Neto D; Baltazar MC; Vasconcellos SA; Vasconcellos ME
Rev Sci Tech; 1993 Sep; 12(3):941-55. PubMed ID: 8219344
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.
Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N
Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2012 Feb; 423(2):297-302. PubMed ID: 22155287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
